
390: FDA turmoil, election intrigue, AI, and more
The Readout Loud
00:00
M&A activity expectations
Jared and Adam discuss merger speculation, deal pacing, and Gilead's acquisition of Arcelix.
Play episode from 02:44
Transcript

Jared and Adam discuss merger speculation, deal pacing, and Gilead's acquisition of Arcelix.